Tracking cfDNA levels may help better evaluate surgery colorectal cancer effectiveness

A new research paper was published in Oncotarget’s Volume 16 on January 21, 2025, titled “Assessment of cfDNA release dynamics during colorectal cancer surgery.”

Gene Therapy Shows Promise in Rare Eye Disease That Causes Early Blindness

A subretinal gene therapy was well tolerated 1 year after treatment, with no drug-related serious adverse events, in a small group of patients with Leber

September 14, 2024

MindBio Therapeutics Enrolls 25th Participant into Landmark Take-Home Microdosing Depression Trial | Psychedelic Invest

Vancouver, British Columbia –TheNewswire –September 23, 2024–MindBio Therapeutics Corp. (CSE: MBIO); (Frankfurt: WF6),(the “Company” or “MindBio”),a leading biopharmaceutical company in psychiatric medicine development, is delighted to report

September 25, 2024

FDA Grants De Novo Request for Neuromodulatory System for Urge Incontinence

The FDA has granted a de novo marketing request for the Revi System for tibial neuromodulation to treat urinary incontinence with or without urinary urgency,

August 19, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.